Passage Bio Stock In The News
| PASG Stock | USD 0.75 0.13 20.97% |
Our overall analysis of Passage Bio's news coverage and content from conventional and social sources shows investors' bearish mood towards Passage Bio. The specific impact of Passage Bio news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Passage Bio's overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Passage Bio headlines in addition to utilizing other, more conventional financial analysis modules. Check out Passage Bio Backtesting and Passage Bio Hype Analysis. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.
Passage |
Passage Bio Today Top News and Investor Outlook
Passage Bio Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Passage and other traded companies coverage with news coverage. We help investors stay connected with Passage headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Passage Stock performance. Please note that trading solely based on the Passage Bio hype is not for everyone as timely availability and quick action are needed to avoid losses.
Passage Bio stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Passage earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. That information is available publicly through Passage media outlets and privately through word of mouth or via Passage internal channels. However, regardless of the origin, that massive amount of Passage data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.
Passage Largest EPS Surprises
Earnings surprises can significantly impact Passage Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.31 | -0.26 | 0.05 | 16 | ||
2024-05-14 | 2024-03-31 | -0.36 | -0.3 | 0.06 | 16 | ||
2024-03-04 | 2023-12-31 | -0.4 | -0.3 | 0.1 | 25 | ||
2022-08-04 | 2022-06-30 | -0.83 | -0.73 | 0.1 | 12 | ||
2022-05-16 | 2022-03-31 | -0.89 | -0.79 | 0.1 | 11 | ||
2023-05-11 | 2023-03-31 | -0.5 | -0.63 | -0.13 | 26 |
Passage Bio Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Passage Bio Stock. Current markets are slightly bearish. About 58% of major world exchanges and indexes are down. See today's market update for more information.
14th of November 2024
Vestal Point Capital, LP Increases Stake in Passage Bio Inc at gurufocus.com
24th of October 2024
Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the Eu... at finance.yahoo.com
2nd of October 2024
Acquisition by Kassberg Thomas Richard of 1741 shares of Passage Bio at 0.7 subject to Rul... at MacroaxisInsider
24th of September 2024
Is Passage Bio In A Good Position To Deliver On Growth Plans at simplywall.st
23rd of September 2024
Passage Bio to Present at Chardans 8th Annual Genetic Medicines Conference at globenewswire.com
18th of September 2024
OrbiMed Advisors sells shares of Passage Bio worth over 146,000 at investing.com
16th of September 2024
Passage Bio to Present Positive Interim Data from Cohort 1 Patients with FTD-GRN in upliFT... at finance.yahoo.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Passage Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Passage Bio's short interest history, or implied volatility extrapolated from Passage Bio options trading.
Check out Passage Bio Backtesting and Passage Bio Hype Analysis. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.04) | Return On Assets (0.34) | Return On Equity (0.64) |
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.